[Immune response in toxoplasmosis after mucosal immunization with Toxoplasma gondii antigens].
Kobets
N V
NV
Zaĭtseva
L G
LG
Goncharov
D B
DB
Gubareva
E V
EV
Mezentseva
M V
MV
Kireeva
I V
IV
Surgucheva
I M
IM
Samoĭlenko
I I
II
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000284:Administration, Oral; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000918:Antibody Specificity; D000953:Antigens, Protozoan / Q000008:administration & dosage / Q000276:immunology*; D002478:Cells, Cultured; D003603:Cytotoxins / Q000032:analysis / Q000235:genetics; D006820:Hyaluronic Acid / Q000008:administration & dosage; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008811:Mice, Inbred DBA; D009061:Mouth Mucosa; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000276:immunology*; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013154:Spleen / Q000276:immunology; D014122:Toxoplasma / Q000276:immunology*; D014123:Toxoplasmosis / Q000097:blood / Q000276:immunology / Q000517:prevention & control*; D014611:Vaccination
D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D003603:Cytotoxins; D016052:Protozoan Vaccines; D012333:RNA, Messenger; D006820:Hyaluronic Acid